vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Roper Technologies (ROP). Click either name above to swap in a different company.

Roper Technologies is the larger business by last-quarter revenue ($2.1B vs $1.2B, roughly 1.7× Alignment Healthcare, Inc.). Roper Technologies runs the higher net margin — 15.8% vs 0.9%, a 14.9% gap on every dollar of revenue. On growth, Roper Technologies posted the faster year-over-year revenue change (11.3% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs 10.5%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

ALHC vs ROP — Head-to-Head

Bigger by revenue
ROP
ROP
1.7× larger
ROP
$2.1B
$1.2B
ALHC
Growing faster (revenue YoY)
ROP
ROP
+86.0% gap
ROP
11.3%
-74.7%
ALHC
Higher net margin
ROP
ROP
14.9% more per $
ROP
15.8%
0.9%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
34.6%
10.5%
ROP

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ALHC
ALHC
ROP
ROP
Revenue
$1.2B
$2.1B
Net Profit
$11.4M
$331.0M
Gross Margin
69.4%
Operating Margin
27.2%
Net Margin
0.9%
15.8%
Revenue YoY
-74.7%
11.3%
Net Profit YoY
53.7%
EPS (diluted)
$4.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
ROP
ROP
Q1 26
$1.2B
$2.1B
Q4 25
$1.0B
$2.1B
Q3 25
$993.7M
$2.0B
Q2 25
$1.0B
$1.9B
Q1 25
$926.9M
$1.9B
Q4 24
$701.2M
$1.9B
Q3 24
$692.4M
$1.8B
Q2 24
$681.3M
$1.7B
Net Profit
ALHC
ALHC
ROP
ROP
Q1 26
$11.4M
$331.0M
Q4 25
$-11.0M
$428.4M
Q3 25
$3.7M
$398.5M
Q2 25
$15.7M
$378.3M
Q1 25
$-9.1M
$331.1M
Q4 24
$-31.1M
$462.3M
Q3 24
$-26.4M
$367.9M
Q2 24
$-24.0M
$337.1M
Gross Margin
ALHC
ALHC
ROP
ROP
Q1 26
69.4%
Q4 25
69.5%
Q3 25
69.5%
Q2 25
69.2%
Q1 25
68.7%
Q4 24
68.3%
Q3 24
69.2%
Q2 24
69.5%
Operating Margin
ALHC
ALHC
ROP
ROP
Q1 26
27.2%
Q4 25
-1.0%
28.6%
Q3 25
0.8%
28.4%
Q2 25
2.2%
28.2%
Q1 25
-0.6%
27.9%
Q4 24
-3.2%
28.0%
Q3 24
-2.8%
28.1%
Q2 24
-2.7%
28.8%
Net Margin
ALHC
ALHC
ROP
ROP
Q1 26
0.9%
15.8%
Q4 25
-1.1%
20.8%
Q3 25
0.4%
19.8%
Q2 25
1.5%
19.5%
Q1 25
-1.0%
17.6%
Q4 24
-4.4%
24.6%
Q3 24
-3.8%
20.8%
Q2 24
-3.5%
19.6%
EPS (diluted)
ALHC
ALHC
ROP
ROP
Q1 26
$4.87
Q4 25
$-0.04
$3.97
Q3 25
$0.02
$3.68
Q2 25
$0.07
$3.49
Q1 25
$-0.05
$3.06
Q4 24
$-0.15
$4.29
Q3 24
$-0.14
$3.40
Q2 24
$-0.13
$3.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
ROP
ROP
Cash + ST InvestmentsLiquidity on hand
$705.6M
$382.9M
Total DebtLower is stronger
$9.7B
Stockholders' EquityBook value
$206.9M
$18.8B
Total Assets
$1.3B
$34.6B
Debt / EquityLower = less leverage
0.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
ROP
ROP
Q1 26
$705.6M
$382.9M
Q4 25
$604.2M
$297.4M
Q3 25
$644.1M
$320.0M
Q2 25
$503.8M
$242.4M
Q1 25
$479.5M
$372.8M
Q4 24
$470.6M
$188.2M
Q3 24
$381.0M
$269.6M
Q2 24
$363.7M
$251.5M
Total Debt
ALHC
ALHC
ROP
ROP
Q1 26
$9.7B
Q4 25
$323.2M
$9.3B
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
$7.6B
Q3 24
$212.0M
Q2 24
$211.7M
Stockholders' Equity
ALHC
ALHC
ROP
ROP
Q1 26
$206.9M
$18.8B
Q4 25
$179.3M
$19.9B
Q3 25
$161.9M
$20.0B
Q2 25
$141.0M
$19.6B
Q1 25
$108.1M
$19.2B
Q4 24
$99.9M
$18.9B
Q3 24
$114.5M
$18.5B
Q2 24
$123.7M
$18.1B
Total Assets
ALHC
ALHC
ROP
ROP
Q1 26
$1.3B
$34.6B
Q4 25
$1.1B
$34.6B
Q3 25
$1.1B
$34.6B
Q2 25
$1.0B
$33.2B
Q1 25
$895.6M
$31.4B
Q4 24
$782.1M
$31.3B
Q3 24
$692.3M
$31.6B
Q2 24
$716.3M
$29.8B
Debt / Equity
ALHC
ALHC
ROP
ROP
Q1 26
0.52×
Q4 25
1.80×
0.47×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
0.40×
Q3 24
1.85×
Q2 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
ROP
ROP
Operating Cash FlowLast quarter
$128.7M
Free Cash FlowOCF − Capex
$507.0M
FCF MarginFCF / Revenue
24.2%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
11.27×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
ROP
ROP
Q1 26
$128.7M
Q4 25
$-50.4M
$738.0M
Q3 25
$144.6M
$869.5M
Q2 25
$29.1M
$404.1M
Q1 25
$16.6M
$528.7M
Q4 24
$-8.7M
$722.2M
Q3 24
$26.2M
$755.4M
Q2 24
$23.5M
$384.1M
Free Cash Flow
ALHC
ALHC
ROP
ROP
Q1 26
$507.0M
Q4 25
$-55.4M
Q3 25
$139.1M
Q2 25
$21.1M
Q1 25
$8.4M
Q4 24
$-18.0M
Q3 24
$16.9M
Q2 24
$11.8M
FCF Margin
ALHC
ALHC
ROP
ROP
Q1 26
24.2%
Q4 25
-5.5%
Q3 25
14.0%
Q2 25
2.1%
Q1 25
0.9%
Q4 24
-2.6%
Q3 24
2.4%
Q2 24
1.7%
Capex Intensity
ALHC
ALHC
ROP
ROP
Q1 26
0.5%
Q4 25
0.5%
Q3 25
0.6%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
1.3%
Q3 24
1.3%
Q2 24
1.7%
Cash Conversion
ALHC
ALHC
ROP
ROP
Q1 26
11.27×
Q4 25
1.72×
Q3 25
38.77×
2.18×
Q2 25
1.86×
1.07×
Q1 25
1.60×
Q4 24
1.56×
Q3 24
2.05×
Q2 24
1.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons